Cart 2

Vorsetuzumab mafodotin reference antibody

Cat.#: 176929

Size:

Special Price 301.5 USD

Availability: In Stock
- +

Add to cart to get an online quotation

Product Information

  • Product Name
    Vorsetuzumab mafodotin reference antibody
  • Documents
  • Description
    Anti-TNFSF7 / CD27L / CD70 Antibody (Vorsetuzumab mafodotin)
  • Tested applications
    ELISA
  • Species reactivity
    Human TNFSF7 / CD27L / CD70
  • Isotype
    IgG1
  • Preparation
    Recombinant expression and purified from CHO cells.
  • Clonality
    Monoclonal
  • Formulation
    0.1 M Pro-Ac, 20 mM Arg, pH 5.0
  • Storage instructions
    -80°C for 2 years under sterile conditions; -20°C for 1 year under sterile conditions; Avoid repeated freeze-thaw cycles.
  • Validations

    SEC-HPLC

    SEC-HPLC

    The purity of Anti-TNFSF7 / CD27L / CD70 Antibody (Vorsetuzumab mafodotin) is 99.29%, determined by SEC-HPLC.

    HIC-HPLC

    HIC-HPLC

    The drug-to-antibody ratio (DAR) of the Anti-TNFSF7 / CD27L / CD70 Antibody (Vorsetuzumab mafodotin) is 3.8.

    ELISA

    ELISA

    Immobilized humanCD70-His at 2 ug/mL (30 μL/well) can bind Anti-TNFSF7 / CD27L / CD70 Antibody (Vorsetuzumab mafodotin) with the EC50 of 0.007612 ug/mL.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"